Resultados de la búsqueda 11-20 of 12263 for Relaxin-2

  1. Neurología - Ensayos clínicos - Mayo Clinic

    Cohort 3 includes (1) CMVpp65 absent and (2) CMVpp65 present GBM.. Patients in all subcohorts except 1.11 and 1.12 currently have unresectable advanced or ...

  2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... 2-6: 500 mg/m2). Patients randomized to B+R will receive 6 cycles of treatment consisting of a rituximab infusion (Cycle 1: 375 mg/m2; Cycles 2-6: 500 mg/m2) ...

  3. Neurología - Ensayos clínicos - Mayo Clinic

    ... 2 focuses on primary or secondary myelofibrosis (MF) displaying mutated ... (2-4) advanced, unresectable breast cancer (up to 6 donors per phenotype ...

  4. Hematología - Ensayos clínicos - Mayo Clinic

    ... 2-6: 500 mg/m2). Patients randomized to B+R will receive 6 cycles of treatment consisting of a rituximab infusion (Cycle 1: 375 mg/m2; Cycles 2-6: 500 mg/m2) ...

  5. Ensayos clínicos - Centro Pediátrico de Mayo Clinic

    The investigators have chosen this population because 1) These mutations are the most common genetic causes of LQTS, and 2) Offspring will have high risk of ...

  6. Medicina Física y Rehabilitación - Ensayos clínicos - Mayo Clinic

    Ir a página 22. A continuación se enumeran ensayos clínicos actuales. 20 estudios en Medicina Física y Rehabilitación (estudios abiertos únicamente). Filtrar ...

  7. Neurología - Ensayos clínicos - Mayo Clinic

    ... (2) Cohort 2 focuses on primary or secondary myelofibrosis (MF) displaying mutated calreticulin (muCALR); (3) Cohort 3 focuses on glioblastoma multiforme ...

  8. Neurología - Ensayos clínicos - Mayo Clinic

    ... (2) Cohort 2 focuses on primary or secondary myelofibrosis (MF) displaying mutated calreticulin (muCALR); (3) Cohort 3 focuses on glioblastoma multiforme ...

  9. Neurología - Ensayos clínicos - Mayo Clinic

    ... (2) Cohort 2 focuses on primary or secondary myelofibrosis (MF) displaying mutated calreticulin (muCALR); (3) Cohort 3 focuses on glioblastoma multiforme ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This randomized phase II trial studies how well olaparib, cediranib maleate, and standard chemotherapy work in treating patients with small cell lung cancer ...